Mono	B:C0039704
-	I:C0039704
sulfonated	I:C0039704
tetrazolium	I:C0039704
salt	I:C0039704
based	O
NAD	B:C0027303
(	I:C0027303
P	I:C0027303
)	I:C0027303
H	I:C0027303
detection	B:C1511790
reagents	B:C0034760
suitable	O
for	O
dehydrogenase	B:C0017786
and	O
real	O
-	O
time	O
cell	B:C0430300
viability	I:C0430300
assays	I:C0430300
.	O

Glutamate	B:C0017786
dehydrogenase	I:C0017786
(	O
Glutamate	B:C0017786
dehydrogenase	I:C0017786
)	O
catalyzes	O
the	O
oxidative	O
deamination	O
of	O
L	B:C0220839
-	I:C0220839
glutamate	I:C0220839
and	O
is	O
important	O
for	O
several	O
biological	B:C3714634
processes	I:C3714634
.	O

For	O
Glutamate	B:C0017786
dehydrogenase	I:C0017786
inhibitor	B:C0014432
screening	B:C0373483
,	O
we	O
developed	O
a	O
novel	O
mono	B:C0039704
-	I:C0039704
sulfonated	I:C0039704
tetrazolium	I:C0039704
salt	I:C0039704
(	O
EZMTT	B:C0039704
)	O
,	O
which	O
can	O
be	O
synthesized	O
using	O
H2O2	B:C0020281
oxidation	B:C0030011
and	O
purified	O
easily	O
on	O
silica	B:C2936385
gel	I:C2936385
in	O
large	O
quantities	O
.	O

The	O
EZMTT	B:C0039704
detection	B:C0449335
method	I:C0449335
showed	O
linear	O
dose	O
responses	O
to	O
NAD	B:C0027303
(	I:C0027303
P	I:C0027303
)	I:C0027303
H	I:C0027303
,	O
dehydrogenase	B:C0017786
concentration	O
and	O
cell	B:C0007584
numbers	I:C0007584
.	O

In	O
E.	B:C0014834
coli	I:C0014834
GDH	B:C0302273
assay	I:C0302273
,	O
the	O
EZMTT	B:C0039704
method	O
showed	O
excellent	O
assay	O
reproducibility	O
with	O
a	O
Z	O
factor	O
of	O
0.9	O
and	O
caused	O
no	B:C0205557
false	I:C0205557
positives	I:C0205557
in	O
the	O
presence	O
of	O
antioxidants	B:C0003402
(	O
such	O
as	O
BME	B:C0025402
)	O
.	O

Using	O
the	O
EZMTT	B:C0039704
-	O
formazan	B:C0016575
-	O
NAD	B:C0027303
(	I:C0027303
P	I:C0027303
)	I:C0027303
H	I:C0027303
system	O
,	O
we	O
showed	O
that	O
EGCG	B:C0059438
is	O
a	O
potent	O
E.	B:C0014834
coli	I:C0014834
Glutamate	B:C0017786
dehydrogenase	I:C0017786
inhibitor	B:C0014432
(	O
IC50	O
45	O
nM	O
)	O
and	O
identified	O
that	O
Ebselen	B:C0058903
,	O
a	O
multifunctional	O
thioredoxin	B:C0039941
reductase	I:C0039941
inhibitor	B:C0014432
,	O
inactivated	O
E.	B:C0014834
coli	I:C0014834
Glutamate	B:C0017786
dehydrogenase	I:C0017786
(	O
IC50	O
213	O
nM	O
)	O
.	O

In	O
cell	B:C1516365
-	I:C1516365
based	I:C1516365
assays	I:C1516365
at	O
0.5	O
mM	O
tetrazolium	B:C0039704
concentration	O
,	O
EZMTT	B:C0039704
showed	O
essentially	O
no	O
toxicity	O
after	O
a	O
3	O
-	O
day	O
incubation	B:C1320226
,	O
whereas	O
40	O
%	O
of	O
inhibition	B:C1524081
was	O
observed	O
for	O
WST	B:C1310765
-	I:C1310765
8	I:C1310765
.	O

In	O
conclusion	O
,	O
EZMTT	B:C0039704
is	O
a	O
novel	O
tetrazolium	B:C0039704
salt	I:C0039704
which	O
provides	O
improved	O
features	O
that	O
are	O
suitable	O
for	O
dehydrogenases	B:C0030016
and	O
real	O
-	O
time	O
cell	B:C1516365
-	I:C1516365
based	I:C1516365
high	B:C2718002
-	I:C2718002
throughput	I:C2718002
screening	I:C2718002
(	O
HTS	O
)	O
.	O

